The Philogen Family Prepares For Commercialization

Published in: Bioprocess Online
Date: 6 September 2022

Philogen announces enrolment of 214 patients in the Nidlegy™ Phase III European clinical trial for the treatment of locally advanced melanoma

Published in: BioSpace
Date: 25 July 2022

Philogen si presenta alla città, Duccio Neri critico sul Biotecnopolo: “La politica ne stia fuori”

Published in: Sienanews
Date: 30 May 2023

Diagnosi in oncologia: al via una partnership tra Philochem e Bracco Imaging (Italian only)

Published in: AboutPharma
Date: 22 March 2022

Philochem and Bracco Imaging Announce a Collaboration on the Development of a Small Molecule for Diagnostic or Medical Imaging Applications

Published in: GlobeNewsWire
Date: 22 March 2022

Philogen announces publication of PET clinical data with proprietary ultra-high affinity FAP-targeting small molecule ligand (OncoFAP)

Published in: BioSpace
Date: 07 January 2022